Global Medical Director, Urothelial Cancer (MD)

Pfizer • New York City, NY

5d • Hybrid

About The Position

The Global Medical Director, Urothelial Cancer reports to a Global Medical Strategy Lead (GMSL), Urothelial Cancer. The role primarily provides support in developing and executing the medical plan and associated tactics. The role is also key in preparing information and materials for Global Medical Affairs Teams (GMAT) and the Global Product Team (GPT) endorsement as needed. They are responsible, at the product/asset level, for the oversight of medical deliverables in association with the medical plan and overall brand strategy commercial. They are a key interface between Pfizer oncology and Pfizer’s broader organization supporting cross functional work with Clinical Trial Study Teams, including, Safety, Oncology Regulatory Strategy, Global Value and Access (and other functions as needed). RESPONSIBILITIES: Responsible for providing support in advancing key deliverables focused on advancing communication around disease state, therapeutic management, and overall product value; Includes, but not limited to medical affairs plans, scientific communication platforms, engagement plans, access initiatives and trial support Supports lightspeed clinical trial execution through working collaboratively with core medical and development functions to assist with Key Opinion Leader (KOL)/Investigator identification and site education and support Connects with Clinical Trial Study teams to advance key deliverables end to end, from study concept through study data read out and closure Leverages KOL network and insights to inform and adapt medical affairs plans, development plans and brand plans Collaborates cross functionally to prepare and drive scientific engagement plans as well as report findings and trends from engagements back to key internal stakeholders Builds relationships with KOLs and other external stakeholders to help gather medical insights to optimize medical and development strategy Supports the development of and execution of an integrated evidence plans Captures, catalogs, and triages prioritized medical insights and unmet needs from regulators, trial PIs/KOLs, Patients, and other R&D stakeholders Understands the needs of other health system stakeholders (e.g., HTAs, payers, providers) as identified by GMAT, and integrated evidence generation teams Identifies appropriate research methods and prioritization of evidence generation activities for development related priorities (incl. R&D-facing RWE) Assists in developing areas of interest and noninterest for Investigator Sponsored Research studies and support the GMSL and regional colleagues in preparing concepts for review and potential endorsement Support these GMSL/Launch lead in developing support for early patient access through sanctioned programs where there is a need to bridge approval and reimbursement, assess implications of Pre-approval Access Programs on the clinical development plan and regulatory status. Supports TA lead/Launch lead in developing. Supports assessment of required framework / guardrails for potential programs Contributes to the Scientific Communications Platform (SCP) to support aligned information/messages related to disease state / landscape, MOA and key data points Aligns with GMSL and publication/content leaders in CoE to introduce evolving evidence from clinical studies, into the communication framework and internal and external communication plans Ensures the medicine-level SCP is aligned to the broader tumor and/or modality scientific narrative and overall brand narrative Supports establishment of Publications Plan based on upcoming data readouts from R&D driven programs, including evidence / meta-analyses designed to address regulatory / safety topics. Support the Strategy/launch lead in preparing for and obtaining endorsement by study team and GPTs Works closely with clinical study teams during data readouts to determine key messages and publication content (aligned to overall publication strategy and Scientific Communications Platform) and works with CoE on execution. Ensures the Publications Plan is aligned with the Scientific Communications Platform Assesses and identifies internal and external education gaps in collaboration with CoEs focused on advancing internal and external understanding of disease state awareness and therapeutic landscape. Ensures educational activities and proposals support the overarching medical and brand plans Collaborates with Pfizer Oncology Medical Affairs functions to identify key priorities for data communication at scientific congresses; review identified materials to ensure medical accuracy. Provides medical support and expertise to the patient advocacy organization to advance our mission of providing an equitable, patient-centric experience for of those undergoing cancer treatment Evaluates innovation platforms and identifies opportunities to create efficiency and improved outcomes across core medical affairs activities. Collaborates with key stakeholders to leverage innovation and expertise of medical

Requirements

• MD with demonstrated experience and understanding of biopharmaceutical drug development.
• Oncology clinical development or Medical Affairs experience needed; relevant academic and clinical Oncology experience will be considered.
• 5+ years of progressive experience in global medical affairs and/or clinical development in a pharmaceutical or biotech organization.
• Knowledge of the Oncology competitive landscape, stakeholder community and demonstrated deep expertise of their TA and medicines they are supporting.
• Excellent interpersonal and communication skills.
• Ability to think strategically with a collaborative mindset and a proven track record of working effectively in diverse teams involving complex multi-functional disciplines.
• Candidate demonstrates a breadth of diverse leadership experiences and capabilities including: the ability to influence and collaborate with peers, develop and coach others, oversee and guide the work of other colleagues to achieve meaningful outcomes and create business impact.
• Work Location Assignment: Hybrid - must be onsite an average of 2.5 days per week
• This position requires permanent work authorization in the United States.

Responsibilities

• Responsible for providing support in advancing key deliverables focused on advancing communication around disease state, therapeutic management, and overall product value
• Supports lightspeed clinical trial execution through working collaboratively with core medical and development functions to assist with Key Opinion Leader (KOL)/Investigator identification and site education and support
• Connects with Clinical Trial Study teams to advance key deliverables end to end, from study concept through study data read out and closure
• Leverages KOL network and insights to inform and adapt medical affairs plans, development plans and brand plans
• Collaborates cross functionally to prepare and drive scientific engagement plans as well as report findings and trends from engagements back to key internal stakeholders
• Builds relationships with KOLs and other external stakeholders to help gather medical insights to optimize medical and development strategy
• Supports the development of and execution of an integrated evidence plans
• Captures, catalogs, and triages prioritized medical insights and unmet needs from regulators, trial PIs/KOLs, Patients, and other R&D stakeholders
• Understands the needs of other health system stakeholders (e.g., HTAs, payers, providers) as identified by GMAT, and integrated evidence generation teams
• Identifies appropriate research methods and prioritization of evidence generation activities for development related priorities (incl. R&D-facing RWE)
• Assists in developing areas of interest and noninterest for Investigator Sponsored Research studies and support the GMSL and regional colleagues in preparing concepts for review and potential endorsement
• Support these GMSL/Launch lead in developing support for early patient access through sanctioned programs where there is a need to bridge approval and reimbursement, assess implications of Pre-approval Access Programs on the clinical development plan and regulatory status.
• Contributes to the Scientific Communications Platform (SCP) to support aligned information/messages related to disease state / landscape, MOA and key data points
• Aligns with GMSL and publication/content leaders in CoE to introduce evolving evidence from clinical studies, into the communication framework and internal and external communication plans
• Ensures the medicine-level SCP is aligned to the broader tumor and/or modality scientific narrative and overall brand narrative
• Supports establishment of Publications Plan based on upcoming data readouts from R&D driven programs, including evidence / meta-analyses designed to address regulatory / safety topics.
• Works closely with clinical study teams during data readouts to determine key messages and publication content (aligned to overall publication strategy and Scientific Communications Platform) and works with CoE on execution.
• Ensures the Publications Plan is aligned with the Scientific Communications Platform
• Assesses and identifies internal and external education gaps in collaboration with CoEs focused on advancing internal and external understanding of disease state awareness and therapeutic landscape.
• Ensures educational activities and proposals support the overarching medical and brand plans
• Collaborates with Pfizer Oncology Medical Affairs functions to identify key priorities for data communication at scientific congresses; review identified materials to ensure medical accuracy.
• Provides medical support and expertise to the patient advocacy organization to advance our mission of providing an equitable, patient-centric experience for of those undergoing cancer treatment
• Evaluates innovation platforms and identifies opportunities to create efficiency and improved outcomes across core medical affairs activities.
• Collaborates with key stakeholders to leverage innovation and expertise of medical

Benefits

• In addition, this position is eligible for participation in Pfizer’s Global Performance Plan with a bonus target of 25.0% of the base salary and eligibility to participate in our share based long term incentive program.
• We offer comprehensive and generous benefits and programs to help our colleagues lead healthy lives and to support each of life’s moments.
• Benefits offered include a 401(k) plan with Pfizer Matching Contributions and an additional Pfizer Retirement Savings Contribution, paid vacation, holiday and personal days, paid caregiver/parental and medical leave, and health benefits to include medical, prescription drug, dental and vision coverage.
• Learn more at Pfizer Candidate Site – U.S. Benefits | (uscandidates.mypfizerbenefits.com).

What This Job Offers

• Job Type: Full-time
• Career Level: Director
• Education Level: Ph.D. or professional degree